To me this points to idea that LymPro may not be a

Quote:

---

To me this points to idea that LymPro may not be a huge hit as we hope for, but a low revenue test with limited not widespread application.

---

...well to me, it points to you doing little to zero due diligence on Lympro. Version 1 is a different and lacking version compared to version 2. This we all know...
If you realized the released data to date is incomplete but telling in nature you wouldn't make that statement on a public message board...explain yourself if you please...

South...